🔴 MDxHealth is trading 6% down in pre-market with no clear catalyst

MDxHealth is trading 5.96% down at $0.63, with no identified company-specific catalyst.

• The stock declined from its September 17, 2026 close of $0.67.
• No new company-specific announcement, earnings update, regulatory action, or analyst catalyst was identified for September 18, 2026; available coverage showed no current headlines.
• The decline is occurring despite constructive broader-market conditions; the immediate catalyst remains unclear and confidence is low.